Akorn Recalls Sodium Chloride Ophthalmic Ointment Due to Particulate Matter
Akorn, Inc. is recalling specific lots of Sodium Chloride Ophthalmic Ointment USP, 5%, due to the presence of brown particulate matter inside the tubes.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which indicates the product is unlikely to cause adverse health consequences. The hazard is limited to particulate matter from the tube material.
Plain-English summary
Akorn, Inc. is recalling 720 tubes of Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes (NDC 17478-622-35). The recall is due to the presence of brown spots observed on the inside of the product tubes. These spots were identified as tin with trace copper, which are the base materials of construction for the tube.
The affected lots are 8B66A (Exp. 01/2021), 8C91A (Exp. 02/2021), 8F07A and 8F16A (Exp. 05/2021), and 8F13A (Exp. 07/2021). The product was distributed nationwide within the United States and Puerto Rico.
Consumers should check their inventory for these specific lot numbers and expiration dates. If the product is found, it should be returned to the source of purchase or the manufacturer.
The recalled product
- Product
- Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-622-35
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 720
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot #: 8B66A
- Exp. Date 01/2021
- Lot 8C91A
- Exp. Date 02/2021
- Lots 8F07A
- 8F16A
- Exp. Date 05/2021
- Lot 8F13A
- Exp. Date 07/2021.
Distribution
Part of a larger recall action
This product is one of 3 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · particulate matter
See all →- ModerateIMAAVY Injection Recalled for Presence of Particulate Matter
FDA (Drugs) · 2026-10-14
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls Plum Administration Sets Due to Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
Similar recalls
- ModerateSodium Chloride Ophthalmic Ointment Recalled for Manufacturing Deviations
FDA (Drugs) · 2023-01-25
- HighSodium Chloride Ophthalmic Ointment Recalled for Turbidity and Sterility Concerns
FDA (Drugs) · 2022-09-14
- ModerateAkorn Sodium Chloride Ophthalmic Ointment Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2023-06-07
- ModerateAkorn Recalls Subpotent Sodium Chloride Ophthalmic Solution
FDA (Drugs) · 2016-11-09
- HighFDA Recalls Akorn AK-POLY-BAC Eye Ointment for CGMP Violations
FDA (Drugs) · 2023-01-25
- ModerateDrug Recall: Erythromycin Ophthalmic Ointment Due to Manufacturing Deviations
FDA (Drugs) · 2023-01-25